[Renal thrombohemolytic microangiopathy (author's transl)].
The clinical findings in three patients with renal thrombohemolytic microangiopathy are presented. The triad of microangiopathic hemolytic anemia, disseminated intravascular coagulation and microangiopathic changes of the kidney leading to renal insufficiency is the characteristic feature of this disease. Beside the usual classification based on etiological factors (distinguishing between primary and symptomatic forms) a topographical classification (distinguishing between generalized forms and localized forms occuring in isolated organs) is suggested. The pathogenesis and therapy of this disorder are discussed.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005260:Female; D006084:Graft Rejection; D006463:Hemolytic-Uremic Syndrome / Q000097:blood / Q000628:therapy; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic; D006435:Renal Dialysis; D014184:Transplantation, Homologous
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants
Renale thrombohämolytische Mikroangiopathie